Zobrazeno 1 - 10
of 69
pro vyhledávání: '"Evgeny Klyuchnikov"'
Autor:
Nico Gagelmann, Christine Wolschke, Anita Badbaran, Dietlinde Janson, Carolina Berger, Evgeny Klyuchnikov, Francis Ayuk, Boris Fehse, Nicolaus Kröger
Publikováno v:
HemaSphere, Vol 7, Iss 7, p e921 (2023)
Hematopoietic cell transplantation (HCT) is a curative approach for myelofibrosis patients, but relapse is a major cause of treatment failure. We investigated the effect of donor lymphocyte infusion (DLI) in 37 patients with molecular (n = 17) or hem
Externí odkaz:
https://doaj.org/article/0cb54fc977df4ed1a50b95c2ca9dd72e
Autor:
Nico Gagelmann, Francis A. Ayuk, Evgeny Klyuchnikov, Christine Wolschke, Susanna Carolina Berger, Nicolaus Kröger
Publikováno v:
Haematologica, Vol 108, Iss 10 (2023)
Externí odkaz:
https://doaj.org/article/6500714330dc4e408008243ae395b75c
Autor:
Nico Gagelmann, Christine Wolschke, Evgeny Klyuchnikov, Maximilian Christopeit, Francis Ayuk, Nicolaus Kröger
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
This analysis aimed to systematically review and synthesize the existing evidence regarding the outcome of tyrosine kinase inhibitor (TKI) maintenance therapy after allogeneic stem-cell transplantation for patients with FLT3-ITD-mutated acute myeloid
Externí odkaz:
https://doaj.org/article/7cf0927a546b49be8b73bd5cdd8cac21
Autor:
Evgeny Klyuchnikov, Ulrike Bacher, Nicolaus Kröger, Ilya Kazantsev, Tatjana Zabelina, Francis Ayuk, Axel Rolf Zander
Publikováno v:
Advances in Hematology, Vol 2011 (2011)
Despite the favorable prognosis of most patients with Hodgkin's Lymphoma (HL), 15–20% of patients remain refractory to chemoradiotherapy, and 20–40% experience relapses following autologous stem cell transplantation (SCT) being used as salvage ap
Externí odkaz:
https://doaj.org/article/cddd005077ba41e29c4e35ef3b93ed42
Autor:
Anthony Oyekunle, Torsten Haferlach, Nicolaus Kröger, Evgeny Klyuchnikov, Axel Rolf Zander, Susanne Schnittger, Ulrike Bacher
Publikováno v:
Advances in Hematology, Vol 2011 (2011)
In recent years, the panel of known molecular mutations in acute lymphoblastic leukemia (ALL) has been continuously increased. In Philadelphia-positive ALL, deletions of the IKZF1 gene were identified as prognostically adverse factors. These improved
Externí odkaz:
https://doaj.org/article/594b0e5b1ed9442fb8f916c853d13dc3
Autor:
Evgeny Klyuchnikov, Claudia Langebrake, Anita Badbaran, Adrin Dadkhah, Radwan Massoud, Petra Freiberger, Francis Ayuk, Dietlinde Janson, Christine Wolschke, Ulrike Bacher, Nicolaus Kröger
Publikováno v:
European Journal of Haematology. 110:188-197
Pre-transplant minimal residual disease (MRD) impacts negatively on post-transplant relapse risk in acute myeloid leukemia (AML). Therapeutic drug monitoring by calculating area under the curve (AUC) was developed to optimize busulfan (Bu) exposure.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8493e341fc18ece453c4fad33989c6a2
https://doi.org/10.1111/ejh.13893
https://doi.org/10.1111/ejh.13893
Autor:
Evgeny Klyuchnikov
Publikováno v:
InFo Hämatologie + Onkologie. 25:10-17
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::532bf330abde02aa028306e25d725aa5
https://doi.org/10.1007/s15004-022-9715-x
https://doi.org/10.1007/s15004-022-9715-x
Autor:
Marlene Luther, Frank Oliver Henes, Tatjana Zabelina, Radwan Massoud, Dietlinde Janson, Christine Wolschke, Evgeny Klyuchnikov, Nico Gagelmann, Boris Fehse, Gerhard Adam, Nicolaus Kröger, Francis Ayuk
Publikováno v:
Bone Marrow Transplantation.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::54d8f9f102a06b99d9d41ad23b21b8b5
https://doi.org/10.1038/s41409-023-01968-8
https://doi.org/10.1038/s41409-023-01968-8
Autor:
Nico Gagelmann, Francis A. Ayuk, Evgeny Klyuchnikov, Christine Wolschke, Susanna Carolina Berger, Nicolaus Kröger
Publikováno v:
Haematologica.
Not available.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c9724c1aac60274bb1ac526b5bb99922
https://doi.org/10.3324/haematol.2022.282510
https://doi.org/10.3324/haematol.2022.282510
Autor:
Anita Badbaran, Ulrike Fritsche-Friedland, Nicolaus Kröger, Ulrike Bacher, Francis Ayuk, Evgeny Klyuchnikov, Dietlinde Janson, Christine Wolschke, Radwan Massoud
Publikováno v:
Transplantation and Cellular Therapy. 27:841-850
Minimal/measurable residual disease (MRD) before allogeneic stem cell transplantation (allo-SCT) in patients with acute myelogenous leukemia (AML) is a poor risk factor for outcome. γδ T cells represent a unique minority lymphocyte population that
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0d8169b17d27ff31f2d15ea5ff2bea82
https://doi.org/10.1016/j.jtct.2021.06.003
https://doi.org/10.1016/j.jtct.2021.06.003